| Year |
Citation |
Score |
| 2000 |
Nakagawa SH, Tager HS, Steiner DF. Mutational analysis of invariant valine B12 in insulin: implications for receptor binding. Biochemistry. 39: 15826-35. PMID 11123908 DOI: 10.1021/Bi001802+ |
0.627 |
|
| 1997 |
Pittman I, Nakagawa SH, Tager HS, Steiner DF. Maintenance of the B-chain beta-turn in [GlyB24] insulin mutants: a steady-state fluorescence anisotropy study. Biochemistry. 36: 3430-7. PMID 9131992 DOI: 10.1021/Bi9624144 |
0.686 |
|
| 1995 |
Pittman I, Tager HS. A spectroscopic investigation of the conformational dynamics of insulin in solution. Biochemistry. 34: 10578-90. PMID 7654714 DOI: 10.1021/Bi00033A033 |
0.526 |
|
| 1994 |
Polonsky KS, Gumbiner B, Ostrega D, Griver K, Tager H, Henry RR. Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM Diabetes. 43: 871-877. PMID 8013750 DOI: 10.2337/Diab.43.7.871 |
0.549 |
|
| 1993 |
Schäffer L, Kjeldsen T, Andersen AS, Wiberg FC, Larsen UD, Cara JF, Mirmira RG, Nakagawa SH, Tager HS. Interactions of a hybrid insulin/insulin-like growth factor-I analog with chimeric insulin/type I insulin-like growth factor receptors. The Journal of Biological Chemistry. 268: 3044-7. PMID 8428981 |
0.467 |
|
| 1993 |
Post SR, Rubinstein PG, Tager HS. Mechanism of action of des-His1-[Glu9]glucagon amide, a peptide antagonist of the glucagon receptor system. Proceedings of the National Academy of Sciences of the United States of America. 90: 1662-6. PMID 8383321 DOI: 10.1073/Pnas.90.5.1662 |
0.362 |
|
| 1993 |
Nakagawa SH, Tager HS. Importance of main-chain flexibility and the insulin fold in insulin-receptor interactions. Biochemistry. 32: 7237-43. PMID 8343513 DOI: 10.1021/Bi00079A021 |
0.59 |
|
| 1993 |
Nakagawa SH, Johansen NL, Madsen K, Schwartz TW, Tager HS. Implications of replacing peptide bonds in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker. International Journal of Peptide and Protein Research. 42: 578-84. PMID 8307689 DOI: 10.1111/J.1399-3011.1993.Tb00367.X |
0.546 |
|
| 1992 |
Nakagawa SH, Tager HS. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions. Biochemistry. 31: 3204-14. PMID 1554705 DOI: 10.1021/Bi00127A023 |
0.499 |
|
| 1992 |
Schaffer L, Markussen J, Kjeldsen T, Andersen AS, Wiberg FC, Tager H. Use of mutant insulin receptors in structure-function studies of insulins Biochemical Society Transactions. 20: 842-843. PMID 1487077 DOI: 10.1042/Bst0200842 |
0.558 |
|
| 1992 |
Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proceedings of the National Academy of Sciences of the United States of America. 89: 251-5. PMID 1346068 DOI: 10.1073/Pnas.89.1.251 |
0.327 |
|
| 1991 |
Nakagawa SH, Tager HS. Implications of invariant residue LeuB6 in insulin-receptor interactions. The Journal of Biological Chemistry. 266: 11502-9. PMID 2050662 |
0.52 |
|
| 1991 |
Brems DN, Brown PL, Nakagawa SH, Tager HS. The conformational stability and flexibility of insulin with an additional intramolecular cross-link. The Journal of Biological Chemistry. 266: 1611-5. PMID 1988440 |
0.341 |
|
| 1991 |
Mirmira RG, Nakagawa SH, Tager HS. Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions. The Journal of Biological Chemistry. 266: 1428-36. PMID 1988428 |
0.546 |
|
| 1991 |
Mirmira RG, Tager HS. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions. Biochemistry. 30: 8222-9. PMID 1868095 DOI: 10.1021/Bi00247A019 |
0.689 |
|
| 1990 |
Steiner DF, Tager HS, Chan SJ, Nanjo K, Sanke T, Rubenstein AH. Lessons learned from molecular biology of insulin-gene mutations. Diabetes Care. 13: 600-9. PMID 2192846 DOI: 10.2337/Diacare.13.6.600 |
0.755 |
|
| 1990 |
Cara JF, Mirmira RG, Nakagawa SH, Tager HS. An insulin-like growth factor I/insulin hybrid exhibiting high potency for interaction with the type I insulin-like growth factor and insulin receptors of placental plasma membranes. The Journal of Biological Chemistry. 265: 17820-5. PMID 2170397 |
0.529 |
|
| 1990 |
Shapiro ET, Bell GI, Polonsky KS, Rubenstein AH, Kew MC, Tager HS. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II. The Journal of Clinical Investigation. 85: 1672-9. PMID 2159026 DOI: 10.1172/Jci114619 |
0.679 |
|
| 1989 |
Mirmira RG, Tager HS. Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation. The Journal of Biological Chemistry. 264: 6349-54. PMID 2649499 |
0.394 |
|
| 1989 |
Nakagawa SH, Tager HS. Perturbation of insulin-receptor interactions by intramolecular hormone cross-linking. Analysis of relative movement among residues A1, B1, and B29. The Journal of Biological Chemistry. 264: 272-9. PMID 2642474 |
0.471 |
|
| 1988 |
Cara JF, Nakagawa SH, Tager HS. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes. Endocrinology. 122: 2881-7. PMID 2967179 DOI: 10.1210/Endo-122-6-2881 |
0.605 |
|
| 1987 |
Nanjo K, Miyano M, Kondo M, Sanke T, Nishimura S, Miyamura K, Inouye K, Given BD, Chan SJ, Polonsky KS, Tager HS, Steiner DF, Rubenstein AH. Insulin Wakayama: familial mutant insulin syndrome in Japan Diabetologia. 30: 87-92. PMID 3552828 DOI: 10.1007/Bf00274577 |
0.808 |
|
| 1987 |
Nanjo K, Miyano M, Kondo M, Sanke T, Nishimura S, Miyamura K, Inouye K, Given BD, Chan SJ, Polonsky KS, Tager HS, Steiner DF, Rubenstein AH. Insulin Wakayama: familial mutant insulin syndrome in Japan Diabetologia. 30: 87-92. PMID 3552828 DOI: 10.1007/BF00274577 |
0.566 |
|
| 1987 |
Nakagawa SH, Tager HS. Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain. The Journal of Biological Chemistry. 262: 12054-8. PMID 3305501 |
0.53 |
|
| 1987 |
Hagopian WA, Tager HS. Hepatic glucagon metabolism. Correlation of hormone processing by isolated canine hepatocytes with glucagon metabolism in man and in the dog. The Journal of Clinical Investigation. 79: 409-17. PMID 2879853 DOI: 10.1172/JCI112827 |
0.331 |
|
| 1986 |
Shoelson SE, Polonsky KS, Nakabayashi T, Jaspan JB, Tager HS. Circulating forms of somatostatinlike immunoreactivity in human plasma. The American Journal of Physiology. 250: E428-34. PMID 3963183 DOI: 10.1152/Ajpendo.1986.250.4.E428 |
0.525 |
|
| 1986 |
Steiner DF, Chan SJ, Welsh JM, Nielsen D, Michael J, Tager HS, Rubenstein AH. Models of peptide biosynthesis: the molecular and cellular basis of insulin production. Clinical and Investigative Medicine. Mã©Decine Clinique Et Experimentale. 9: 328-36. PMID 3542328 |
0.733 |
|
| 1986 |
Nakagawa SH, Tager HS. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects. The Journal of Biological Chemistry. 261: 7332-41. PMID 3519607 |
0.464 |
|
| 1986 |
Polonsky K, Frank B, Pugh W, Addis A, Karrison T, Meier P, Tager H, Rubenstein A. The limitations to and valid use of C-peptide as a marker of the secretion of insulin Diabetes. 35: 379-386. PMID 3514322 DOI: 10.2337/Diab.35.4.379 |
0.658 |
|
| 1986 |
Cohen RM, Given BD, Licinio-Paixao J, Provow SA, Rue PA, Frank BH, Root MA, Polonsky KS, Tager HS, Rubenstein AH. Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia. Metabolism: Clinical and Experimental. 35: 1137-46. PMID 3023795 DOI: 10.1016/0026-0495(86)90027-2 |
0.73 |
|
| 1985 |
Given BD, Cohen RM, Shoelson SE, Frank BH, Rubenstein AH, Tager HS. Biochemical and clinical implications of proinsulin conversion intermediates. The Journal of Clinical Investigation. 76: 1398-405. PMID 3902891 DOI: 10.1172/Jci112116 |
0.795 |
|
| 1985 |
Robbins DC, Shoelson SE, Tager HS, Mead PM, Gaynor DH. Products of therapeutic insulins in the blood of insulin-dependent (type I) diabetic patients. Diabetes. 34: 510-9. PMID 3886464 DOI: 10.2337/Diab.34.5.510 |
0.732 |
|
| 1984 |
Polonsky KS, Pugh W, Jaspan JB, Cohen DM, Karrison T, Tager HS, Rubenstein AH. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. The Journal of Clinical Investigation. 74: 1821-9. PMID 6389599 DOI: 10.1172/Jci111601 |
0.707 |
|
| 1984 |
Naithani VK, Steffens GJ, Tager HS, Buse G, Rubenstein AH, Steiner DF. Isolation and amino-acid sequence determination of monkey insulin and proinsulin. Hoppe-Seyler's Zeitschrift Fã¼R Physiologische Chemie. 365: 571-5. PMID 6381277 DOI: 10.1515/Bchm2.1984.365.1.571 |
0.775 |
|
| 1984 |
Tager HS. Lilly lecture 1983. Abnormal products of the human insulin gene. Diabetes. 33: 693-9. PMID 6376225 DOI: 10.2337/Diab.33.7.693 |
0.654 |
|
| 1984 |
Shoelson SE, Polonsky KS, Zeidler A, Rubenstein AH, Tager HS. Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model. The Journal of Clinical Investigation. 73: 1351-8. PMID 6371057 DOI: 10.1172/Jci111338 |
0.808 |
|
| 1984 |
Robbins DC, Tager HS, Rubenstein AH. Biologic and clinical importance of proinsulin. The New England Journal of Medicine. 310: 1165-75. PMID 6369137 DOI: 10.1056/Nejm198405033101807 |
0.732 |
|
| 1984 |
Robbins DC, Shoelson SE, Rubenstein AH, Tager HS. Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion. The Journal of Clinical Investigation. 73: 714-9. PMID 6368587 DOI: 10.1172/Jci111264 |
0.802 |
|
| 1984 |
Schwartz TW, Hansen HF, Håkanson R, Sundler F, Tager HS. Human pancreatic icosapeptide: isolation, sequence, and immunocytochemical localization of the COOH-terminal fragment of the pancreatic polypeptide precursor. Proceedings of the National Academy of Sciences of the United States of America. 81: 708-12. PMID 6366786 DOI: 10.1073/Pnas.81.3.708 |
0.406 |
|
| 1984 |
Musso GF, Assoian RK, Kaiser ET, Kézdy FJ, Tager HS. Heterogeneity of glucagon receptors of rat hepatocytes: a synthetic peptide probe for the high affinity site. Biochemical and Biophysical Research Communications. 119: 713-9. PMID 6324771 DOI: 10.1016/S0006-291X(84)80309-5 |
0.372 |
|
| 1984 |
Hagopian WA, Tager HS. Receptor binding and cell-mediated metabolism of [125I]monoiodoglucagon by isolated canine hepatocytes. The Journal of Biological Chemistry. 259: 8986-93. PMID 6086619 |
0.342 |
|
| 1984 |
Tager HS. Glucagon-containing and glucagon-related peptides: Evolutionary, structural and biosynthetic considerations Fernstrom Foundation Series. 285-311. |
0.318 |
|
| 1984 |
Tager HS. Glucagon-containing and glucagon-related peptides: Evolutionary, structural and biosynthetic considerations Fernstrom Foundation Series. 285-311. |
0.318 |
|
| 1983 |
Shoelson S, Fickova M, Haneda M, Nahum A, Musso G, Kaiser ET, Rubenstein AH, Tager H. Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Proceedings of the National Academy of Sciences of the United States of America. 80: 7390-4. PMID 6424111 DOI: 10.1073/Pnas.80.24.7390 |
0.817 |
|
| 1983 |
Green A, Frank BH, Rubenstein A, Tager H, Olefsky JM. Characteristics of binding of a low affinity, noncooperative insulin ([Leu(B25)]insulin) to IM-9 lymphocytes Endocrinology. 113: 1963-1970. PMID 6357764 DOI: 10.1210/Endo-113-6-1963 |
0.709 |
|
| 1983 |
Figlewicz DP, Best JD, Tager HS, Taborsky GJ. [LeuB24]insulin is an insulin agonist at the liver in vivo. The American Journal of Physiology. 245: E483-8. PMID 6356934 |
0.508 |
|
| 1983 |
Polonsky K, Jaspan J, Pugh W, Cohen D, Schneider M, Schwartz T, Moossa AR, Tager H, Rubenstein AH. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. The Journal of Clinical Investigation. 72: 1114-23. PMID 6350363 DOI: 10.1172/Jci111036 |
0.663 |
|
| 1983 |
Shoelson S, Haneda M, Blix P, Nanjo A, Sanke T, Inouye K, Steiner D, Rubenstein A, Tager H. Three mutant insulins in man Nature. 302: 540-543. PMID 6339950 DOI: 10.1038/302540A0 |
0.806 |
|
| 1983 |
Kwok SC, Steiner DF, Rubenstein AH, Tager HS. Identification of a point mutation in the human insulin gene giving rise to a structurally abnormal insulin (insulin Chicago). Diabetes. 32: 872-5. PMID 6313457 DOI: 10.2337/Diab.32.9.872 |
0.754 |
|
| 1983 |
Soybel D, Jaspan J, Polonsky K, Goldberg I, Rayfield E, Tager H. Differential immunoreactivity of plasma glucagon components in man: studies with different glucagon antibodies. The Journal of Clinical Endocrinology and Metabolism. 56: 612-8. PMID 6185527 DOI: 10.1210/Jcem-56-3-612 |
0.301 |
|
| 1983 |
Schwartz TW, Tager HS. Symposium 6. Peptide Chemistry. Synthesis, Receptors Chairmen: J.F. Rehfeld and J. MorleyIsolation from canine, ovine, and human pancreas of a new icosapeptide cosynthesized with pancreatic-polypeptide Regulatory Peptides. 5: 97. DOI: 10.1016/0167-0115(83)90769-3 |
0.375 |
|
| 1983 |
Figlewicz DP, Best JD, Tager HS, Taborsky GJ. [Leu(B24)]insulin is an insulin agonist at the liver in vivo American Journal of Physiology - Endocrinology and Metabolism. 8: E483-E488. |
0.5 |
|
| 1983 |
Figlewicz DP, Best JD, Tager HS, Taborsky GJ. [Leu(B24)]insulin is an insulin agonist at the liver in vivo American Journal of Physiology - Endocrinology and Metabolism. 8: E483-E488. |
0.5 |
|
| 1982 |
Assoian RK, Tager HS. Peptide intermediates in the cellular metabolism of insulin. The Journal of Biological Chemistry. 257: 9078-85. PMID 7047534 |
0.547 |
|
| 1982 |
Assoian RK, Thomas NE, Kaiser ET, Tager HS. [LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs. Proceedings of the National Academy of Sciences of the United States of America. 79: 5147-51. PMID 6752939 DOI: 10.1073/Pnas.79.17.5147 |
0.646 |
|
| 1982 |
Green A, Tager H, Rubenstein A, Frank B, Olefsky JM. Internalization and degradation of a low affinity insulin ([LeuB24]insulin) by rat adipocytes Febs Letters. 144: 255-258. PMID 6749549 DOI: 10.1016/0014-5793(82)80649-2 |
0.7 |
|
| 1982 |
Bonnevie-Nielsen V, Polonsky KS, Jaspan JJ, Rubenstein AH, Schwartz TW, Tager HS. Surface receptors for pancreatic hormones in dog and rat hepatocytes: qualitative and quantitative differences in hormone-target cell interactions. Proceedings of the National Academy of Sciences of the United States of America. 79: 2167-71. PMID 6285368 DOI: 10.1073/Pnas.79.7.2167 |
0.537 |
|
| 1982 |
Figlewicz DP, Tager H, Taborsky GJ. Leu-B24-insulin does not antagonize insulin action at the liver in vivo Diabetes. 31: No. 57. |
0.501 |
|
| 1981 |
Robbins DC, Blix PM, Rubenstein AH, Kanazawa Y, Kosaka K, Tager HS. A human proinsulin variant at arginine 65. Nature. 291: 679-81. PMID 7242673 DOI: 10.1038/291679A0 |
0.741 |
|
| 1981 |
Tager HS, Steiner DF, Patzelt C. Biosynthesis of insulin and glucagon. Methods in Cell Biology. 23: 73-88. PMID 7035811 DOI: 10.1016/S0091-679X(08)61492-2 |
0.754 |
|
| 1981 |
Schwartz TW, Tager HS. Isolation and biogenesis of a new peptide from pancreatic islets. Nature. 294: 589-91. PMID 7031480 DOI: 10.1038/294589A0 |
0.5 |
|
| 1981 |
Olefsky JM, Green A, Ciaraldi TP, Saekow M, Rubenstein AH, Tager HS. Relationship between negative cooperativity and insulin action. Biochemistry. 20: 4488-92. PMID 7025901 DOI: 10.1021/Bi00518A038 |
0.701 |
|
| 1981 |
Assoian RK, Tager HS. [(125I]IodotyrosylB1]insulin. Semisynthesis, receptor binding, and cell-mediated degradation of a B chain-labeled insulin. The Journal of Biological Chemistry. 256: 4042-9. PMID 7012148 |
0.499 |
|
| 1980 |
Given BD, Mako ME, Tager HS, Baldwin D, Markese J, Rubenstein AH, Olefsky J, Kobayashi M, Kolterman O, Poucher R. Diabetes due to secretion of an abnormal insulin. The New England Journal of Medicine. 302: 129-35. PMID 7350438 DOI: 10.1056/Nejm198001173020301 |
0.705 |
|
| 1980 |
Schwartz TW, Gingerich RL, Tager HS. Biosynthesis of pancreatic polypeptide. Identification of a precursor and a co-synthesized product. The Journal of Biological Chemistry. 255: 11494-8. PMID 7002924 |
0.327 |
|
| 1980 |
Tager H, Thomas N, Assoian R, Rubenstein A, Saekow M, Olefsky J, Kaiser ET. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. Proceedings of the National Academy of Sciences of the United States of America. 77: 3181-5. PMID 6997872 DOI: 10.1073/Pnas.77.6.3181 |
0.719 |
|
| 1980 |
Steiner DF, Quinn PS, Chan SJ, Marsh J, Tager HS. Processing mechanisms in the biosynthesis of proteins. Annals of the New York Academy of Sciences. 343: 1-16. PMID 6994549 DOI: 10.1111/J.1749-6632.1980.Tb47238.X |
0.539 |
|
| 1980 |
Olefsky JM, Saekow M, Tager H, Rubenstein AH. Characterization of a mutant human insulin species Journal of Biological Chemistry. 255: 6098-6105. PMID 6993466 |
0.6 |
|
| 1980 |
Assoian RK, Blix PM, Rubenstein AH, Tager HS. Iodotyrosylation of peptides using tertiary-Butyloxycarbonyl-L-[125I]iodotyrosine N-hydroxysuccinimide ester. Analytical Biochemistry. 103: 70-6. PMID 6990829 DOI: 10.1016/0003-2697(80)90238-9 |
0.547 |
|
| 1980 |
Tager H, Hohenboken M, Markese J, Dinerstein RJ. Identification and localization of glucagon-related peptides in rat brain Proceedings of the National Academy of Sciences of the United States of America. 77: 6229-6233. PMID 6934548 DOI: 10.1073/Pnas.77.10.6229 |
0.413 |
|
| 1980 |
Patzelt C, Tager HS, Carroll RJ, Steiner DF. Identification of prosomatostatin in pancreatic islets. Proceedings of the National Academy of Sciences of the United States of America. 77: 2410-4. PMID 6771754 DOI: 10.1073/Pnas.77.5.2410 |
0.641 |
|
| 1980 |
Pilkis SJ, El-Maghrabi MR, Coven B, Claus TH, Tager HS, Steiner DF, Keim PS, Heinrikson RL. Phosphorylation of rat hepatic fructose-1,6-bisphosphatase and pyruvate kinase. The Journal of Biological Chemistry. 255: 2770-5. PMID 6244292 |
0.45 |
|
| 1980 |
Patzelt C, Neilsen D, Carroll R, Quinn P, Lernmark A, Tager HS, Steiner DF. Studies on the biosynthesis of the other peptide hormones of the rat islets of Langerhans. Biochemical Society Transactions. 8: 411-3. PMID 6108881 DOI: 10.1042/Bst0080411 |
0.593 |
|
| 1980 |
Steiner DF, Patzelt C, Chan SJ, Quinn PS, Tager HS, Nielsen D, Lernmark A, Noyes BE, Agarwal KL, Gabbay KH, Rubenstein AH. Formation of biologically active peptides. Proceedings of the Royal Society of London. Series B, Biological Sciences. 210: 45-59. PMID 6107930 DOI: 10.1098/Rspb.1980.0117 |
0.77 |
|
| 1980 |
Tager HS, Patzelt C, Assoian RK, Chan SJ, Duguid JR, Steiner DF. Biosynthesis of islet cell hormones. Annals of the New York Academy of Sciences. 343: 133-47. PMID 6104939 DOI: 10.1111/J.1749-6632.1980.Tb47247.X |
0.525 |
|
| 1980 |
Kramer KJ, Tager HS, Childs CN. Insulin-like and glucagon-like peptides in insect hemolymph Insect Biochemistry. 10: 179-182. DOI: 10.1016/0020-1790(80)90071-2 |
0.612 |
|
| 1980 |
Kramer KJ, Tager HS, Childs CN. Insulin-like and glucagon-like peptides in insect hemolymph Insect Biochemistry. 10: 179-182. DOI: 10.1016/0020-1790(80)90071-2 |
0.568 |
|
| 1980 |
Tager HS, Kramer KJ. Insect glucagon-like peptides: Evidence for a high molecular weight form in midgut from Manducta sexta (L.) Insect Biochemistry. 10: 617-619. DOI: 10.1016/0020-1790(80)90050-5 |
0.425 |
|
| 1979 |
Patzelt C, Tager HS, Carroll RJ, Steiner DF. Identification and processing of proglucagon in pancreatic islets. Nature. 282: 260-6. PMID 388230 DOI: 10.1038/282260A0 |
0.577 |
|
| 1979 |
Tager H, Given B, Baldwin D, Mako M, Markese J, Rubenstein A, Olefsky J, Kobayashi M, Kolterman O, Poucher R. A structurally abnormal insulin causing human diabetes Nature. 281: 122-125. PMID 381941 DOI: 10.1038/281122A0 |
0.709 |
|
| 1979 |
Tager H, Given B, Mako M. Characterization of an abnormal insulin from a patient with diabetes Clinical Research. 27: 378A. |
0.387 |
|
| 1977 |
Kramer KJ, Tager HS, Childs CN, Speirs RD. Insulin-like hypoglycemic and immunological activities in honeybee royal jelly. Journal of Insect Physiology. 23: 293-5. PMID 853242 DOI: 10.1016/0022-1910(77)90044-0 |
0.649 |
|
| 1977 |
Tager HS, Hohenboken M, Markese J. High titer glucagon antisera. Endocrinology. 100: 367-72. PMID 832629 DOI: 10.1210/Endo-100-2-367 |
0.34 |
|
| 1977 |
Scarlett JA, Mako ME, Rubenstein AH, Blix PM, Goldman J, Horwitz DL, Tager H, Jaspan JB, Stjernholm MR, Olefsky JM. Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies New England Journal of Medicine. 297: 1029-1032. PMID 198659 DOI: 10.1056/Nejm197711102971903 |
0.731 |
|
| 1976 |
Tager HS, Markese J, Kramer KJ, Speirs RD, Childs CN. Glucagon-like and insulin-like hormones of the insect neurosecretory system. The Biochemical Journal. 156: 515-20. PMID 949334 DOI: 10.1042/Bj1560515 |
0.611 |
|
| 1976 |
Taylor J, Tager HS, Kaplan EL. A hypercalcemic factor in commercially prepared insulin. The Journal of Surgical Research. 20: 361-4. PMID 933490 DOI: 10.1016/0022-4804(76)90026-3 |
0.573 |
|
| 1976 |
Tager HS, Markese J. Immunoreactive "glucagons" in pancreatic islets. Metabolism: Clinical and Experimental. 25: 1343-6. PMID 790085 DOI: 10.1016/S0026-0495(76)80138-2 |
0.385 |
|
| 1976 |
Lernmark A, Chan SJ, Choy R, Nathans A, Carroll R, Tager HS, Rubenstein AH, Swift HH, Steiner DF. Biosynthesis of insulin and glucagon: a view of the current state of the art. Ciba Foundation Symposium. 41: 7-30. PMID 780079 |
0.769 |
|
| 1975 |
Tager HS, Rubenstein AH, Steiner DF. Methods for the assessment of peptide precursors. Studies insulin biosynthesis. Methods in Enzymology. 37: 326-45. PMID 1092957 DOI: 10.1016/S0076-6879(75)37030-4 |
0.653 |
|
| 1975 |
Tager HS, Rubenstein AH, Steiner DF. [28] Methods for the assessment of peptide precursors. Studies on insulin biosynthesis Methods in Enzymology. 37: 326-345. DOI: 10.1016/S0076-6879(75)37030-4 |
0.746 |
|
| 1975 |
Tager HS, Rubenstein AH, Steiner DF. [28] Methods for the assessment of peptide precursors. Studies on insulin biosynthesis Methods in Enzymology. 37: 326-345. DOI: 10.1016/S0076-6879(75)37030-4 |
0.528 |
|
| 1974 |
Steiner DF, Kemmler W, Tager HS, Rubenstein AH. Molecular events taking place during intracellular transport of exportable proteins. The conversion of peptide hormone precursors. Advances in Cytopharmacology. 2: 195-205. PMID 4613155 |
0.503 |
|
| 1974 |
Steiner DF, Kemmler W, Tager HS, Peterson JD. Proteolytic processing in the biosynthesis of insulin and other proteins. Federation Proceedings. 33: 2105-15. PMID 4370934 |
0.636 |
|
| 1974 |
Tager HS, Steiner DF. Peptide hormones. Annual Review of Biochemistry. 43: 509-38. PMID 4368999 DOI: 10.1146/annurev.bi.43.070174.002453 |
0.535 |
|
| 1973 |
Tager HS, Emdin SO, Clark JL, Steiner DF. Studies on the conversion of proinsulin to insulin. II. Evidence for a chymotrypsin-like cleavage in the connecting peptide region of insulin precursors in the rat. The Journal of Biological Chemistry. 248: 3476-82. PMID 4573980 |
0.699 |
|
| 1973 |
Tager HS, Steiner DF. Isolation of a glucagon-containing peptide: primary structure of a possible fragment of proglucagon. Proceedings of the National Academy of Sciences of the United States of America. 70: 2321-5. PMID 4525166 DOI: 10.1073/Pnas.70.8.2321 |
0.552 |
|
| 1973 |
Steiner DF, Peterson JD, Tager H, Emdin S, Ostberg Y, Falkmer S. Comparative aspects of proinsulin and insulin structure and biosynthesis Integrative and Comparative Biology. 13: 591-604. DOI: 10.1093/Icb/13.3.591 |
0.685 |
|
| 1972 |
Tager HS, Steiner DF. Primary structures of the proinsulin connecting peptides of the rat and the horse. The Journal of Biological Chemistry. 247: 7936-40. PMID 4640931 |
0.495 |
|
| 1972 |
Tager HS, Christensen HN. 2-Aminonorbornane-2-carboxylic acid. Preparation, properties, and identification of the four isomers Journal of the American Chemical Society. 94: 968-972. DOI: 10.1021/Ja00758A041 |
0.437 |
|
| 1971 |
Tager HS, Christensen HN. Hypoglycemic action of 2-aminonorbornane-2-carboxylic acid in the rat. Biochemical and Biophysical Research Communications. 44: 185-91. PMID 5116508 DOI: 10.1016/S0006-291X(71)80176-6 |
0.588 |
|
| 1971 |
Tager HS, Christensen HN. Transport of the four isomers of 2-aminonorbornane-2-carboxylic acid in selected mammalian systems and in Escherichia coli. The Journal of Biological Chemistry. 246: 7572-80. PMID 4944313 |
0.421 |
|
| 1971 |
Christensen HN, Hellman B, Lernmark A, Sehlin J, Tager HS, Täljedal IB. In vitro stimulation of insulin release by non-metabolizable, transport-specific amino acids. Biochimica Et Biophysica Acta. 241: 341-8. PMID 4110546 DOI: 10.1016/0005-2736(71)90034-4 |
0.642 |
|
| 1969 |
Christensen HN, Handlogten ME, Lam I, Tager HS, Zand R. A bicyclic amino acid to improve discriminations among transport systems. The Journal of Biological Chemistry. 244: 1510-20. PMID 4886308 |
0.435 |
|
| Show low-probability matches. |